EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets

Mayank Dalakoti, Salim Virani

American Journal of Preventive Cardiology · 2024-09 · 19 · 100720

DOI: 10.1016/j.ajpc.2024.100720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2024-09. Verfasst von Mayank Dalakoti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National University Heart Centre, Singapore. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Central illustration. Coloured bars in the left panel show the impact of age and ethnicity on an individual's lifetime ASCVD risk mediated by cumulative exposure to LDL-C. Even younger individuals with a greater cumulative exposure to LDL-C, despite their age, may have a higher overall risk compared to older individuals with a lower cumulative exposure to LDL-C.Image, graphical abstract.

Schlagwörter

Stichwörter der Autor:innen

LDL-CLipidsPreventive cardiologyPrimary preventionPrimordial prevention

Autor:innen und Institutionen

  • Department of Cardiology, National University Heart Centre, Singapore.
  • Department of Medicine, Ng Teng Fong General Hospital, Singapore.
  • Department of Public Health and Primary Care, University of Cambridge, United Kingdom.
  • Department of Medicine, The Aga Khan University, Karachi, Pakistan.
  • The Texas Heart Institute, Houston, TX, USA.
  • Section of Cardiovascular Research, Baylor College of Medicine, USA.

Zitieren

APA

Dalakoti, M., & Virani, S. (2024). Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets. American Journal of Preventive Cardiology, 19, 100720. https://doi.org/10.1016/j.ajpc.2024.100720

Vancouver

Dalakoti M, Virani S. Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets. American Journal of Preventive Cardiology. 2024;19:100720. doi:10.1016/j.ajpc.2024.100720

BibTeX
@article{Dalakoti2024,
  author = {Dalakoti, Mayank and Virani, Salim},
  title = {Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets},
  journal = {American Journal of Preventive Cardiology},
  year = {2024},
  volume = {19},
  pages = {100720},
  doi = {10.1016/j.ajpc.2024.100720}
}
Kostenlos starten →